Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-05-31

FDA Approved: ADAPALENE AND BENZOYL PEROXIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a new original application for a topical combination of adapalene and benzoyl peroxide for acne vulgaris, developed by Padagis Israel Pharmaceutica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene and benzoyl peroxide (adapalene; benzoyl peroxide)

Snippet

ORIG AP for ADAPALENE AND BENZOYL PEROXIDE (ADAPALENE AND BENZOYL PEROXIDE)